Clinical Trial Update: All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

This document reports on a Phase 3 trial evaluating all-trans retinoic acid added to standard induction and consolidation therapy in older patients with newly d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)

Snippet

Sponsor: University of Ulm | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED